Abstract:The cardiovascular complications contribute to a majority of diabetes associated morbidity and mortality, accounting for 44% of death in those patients with type 1 diabetes mellitus (DM) and 52% of deaths in type 2 DM. Diabetes elicits cardiovascular dysfunction through 2 major mechanisms: ischemic and non-ischemic. Non-ischemic injury is usually under-recognized although common in DM patients, and also a pathogenic factor of heart failure in those diabetic individuals complicated with ischemic heart disease. Diabetic cardiomyopathy (DCM) is defined as a heart disease in which the myocardium is structurally and functionally abnormal in the absence of coronary artery disease, hypertensive, valvular, or congenital heart disorders in diabetic patients, theoretically caused by non-ischemic injury solely. Current therapeutic strategies targeting DCM mainly address the increased blood glucose levels, however, the effects on heart function are disappointed. Accumulating data indicate endothelial dysfunction plays a critical role in the initiation and development of DCM. Hyperglycemia, hyperinsulinemia, and insulin resistance cause the damages of endothelial function, including barrier dysfunction, impaired nitric oxide (NO) activity, excessive reactive oxygen species (ROS) production, oxidative stress, and inflammatory dysregulation. In turn, endothelial dysfunction promotes impaired myocardial metabolism, intracellular Ca 2+ mishandling, endoplasmic reticulum (ER) stress, mitochondrial defect, accumulation of advanced glycation end products, and extracellular matrix (ECM) deposit, leads to cardiac stiffness, fibrosis, and remodeling, eventually results in cardiac diastolic dysfunction, systolic dysfunction, and heart failure. While endothelial dysfunction is closely related to cardiac dysfunction and heart failure seen in DCM, clinical strategies for restoring endothelial function are still missing. This review summarizes the timely findings related to the effects of endothelial dysfunction on the disorder of myocardium as well as cardiac function, provides mechanical insights in pathogenesis and pathophysiology of DCM developing, and highlights potential therapeutic targets.

Signaling Pathways Related to Oxidative Stress in Diabetic Cardiomyopathy

Signaling Pathways Related to Oxidative Stress in Diabetic Cardiomyopathy

Oxidative Stress Signaling Mediated Pathogenesis of Diabetic Cardiomyopathy

Role of Differential Signaling Pathways and Oxidative Stress in Diabetic Cardiomyopathy

Research Progress on the Mechanism of Action of Reactive Oxygen Species in Diabetic Cardiomyopathy

Oxidative stress and stress signaling: menace of diabetic cardiomyopathy

Therapeutic potential of targeting oxidative stress in diabetic cardiomyopathy

Oxidative stress signaling in the pathogenesis of diabetic cardiomyopathy and the potential therapeutic role of antioxidant naringenin

Relationship between oxidative stress and nuclear factor-erythroid-2-related factor 2 signaling in diabetic cardiomyopathy (Review)

Insights for Oxidative Stress and mTOR Signaling in Myocardial Ischemia/Reperfusion Injury under Diabetes

Role of Oxidative Stress in Diabetic Cardiomyopathy

Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence

Mechanistic Insight into Oxidative Stress-Triggered Signaling Pathways and Type 2 Diabetes

The Impact of Oxidative Stress-Induced Mitochondrial Dysfunction on Diabetic Microvascular Complications.

Oxidative Stress and Diabetic Cardiomyopathy: A Brief Review

NADPH Oxidase Mediates Oxidative Stress and Ventricular Remodeling through SIRT3/FOXO3a pathway in Diabetic Mice

Profile of crosstalk between glucose and lipid metabolic disturbance and diabetic cardiomyopathy: Inflammation and oxidative stress

Diabetic cardiomyopathy and its mechanisms: Role of oxidative stress and damage

Endothelial Dysfunction and Diabetic Cardiomyopathy

Molecular mechanisms of metabolic dysregulation in diabetic cardiomyopathy